Merkel Cell Carcinoma

Practical Management Pearls for Immunotherapy for the Treatment of Nonmelanoma Skin Cancer

A Retrospective Study of Ipilimumab Plus Nivolumab in Anti-PD-L1/PD-1 Refractory Merkel Cell Carcinoma

We present a retrospective study of Ipi/Nivo in refractory MCC.

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer

Society guidelines for the management of NMSC.

Diagnostic Yield of Staging Brain MRI in Merkel Cell Carcinoma

Real world evaluation of initial brain MRI in MCC

Real-world assessment of ipi-nivo in anti-PD-(L)-1 refractory Merkel Cell Carcinoma

Real world evaluation of ipilimumab/nivolumab in PD-1/PDL-1 refractory MCC

Merkel Cell Carcinoma - Current Concepts in Diagnosis and Management

Pearls on the current concepts in diagnosis and management of MCC

Real-world assessment of ipi-nivo in anti-PD-(L)-1 refractory Merkel Cell Carcinoma

Real world evaluation of ipilimumab/nivolumab in PD-1/PDL-1 refractory MCC

Accelerate Health

The Merkel Cell Carcinoma Patient Registry-From Promise to Prototype to Patient

We present a white paper outlining the objectives and applications of the Merkel Cell Carcinoma Patient Registry.

The MCC Patient Registry - From Promise to Prototype to Patient